Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

NOAA will be collaborating with Google's DeepMind and will evaluate the new models and provide feedback to Google's AI ...

Google DeepMind has officially launched Gemma 3n, the latest version of its lightweight generative AI model designed ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...

For a company long defined by proprietary development, this move is a symbol of a broader technological undercurrent sweeping ...

Ruoming Pang previously ran Apple's in-house team that trained the AI foundation models that underpin Apple Intelligence and ...